Dr. Peder Holk Nielsen has been the Chief Executive Officer and President of Novozymes A/S since April 1, 2013. Mr. Nielsen served as an Executive Vice President of Enzyme Business at Novozymes A/S from 2007 to April 1, 2013. He served as the Head of Enzymes Business at Novozymes A/S. Mr. Nielsen served as an Executive Vice President of Sales & Marketing at Novozymes A/S. He served as Corporate Vice president for Enzyme Development & Industrial Biotechnology at Novo Nordisk. He serves as a Director of Hempel (China) Ltd., LEO Pharma A/S and Hempel A/S. He served as a Member of Advisory Board at Center for Biocatalysis and Bioprocessing. Mr. Nielsen holds an MS and PhD from Technical University of Denmark and has a B.Com from Copenhagen Business School.
Venezuelan Opposition Leader María Corina Machado to Receive Concordia’s 2026 Leadership Award for Public Sector
The Concordia Leadership Council is proud to announce María Corina Machado, leader of Venezuela’s democracy movement, as the third and final recipient of the 2026 Concordia Leadership Award, recognized for
